Search results
Results from the WOW.Com Content Network
In May 2015, the company announced its intention to acquire Stage Cell Therapeutics for up to $223 million. [6] Later in the same month the company launched a collaboration, with Editas Medicine , to create CAR-T and high-affinity T cell receptor therapies to treat cancer, with the potential to generate up to $737 million-plus for Editas. [ 7 ]
CAR T cells destroy cells through several mechanisms, including extensive stimulated cell proliferation, increasing the degree to which they are toxic to other living cells (cytotoxicity), and by causing the increased secretion of factors that can affect other cells such as cytokines, interleukins and growth factors.
American Axle & Manufacturing Holdings, Inc. AXL: US American Campus Communities, Inc. ACC: US American Eagle Outfitters, Inc. AEO: US American Electric Power Company: AEP: US American Equity Investment Life Holding Company AEL: US American Express Company: AXP: US American Financial Group Inc. AFG: US American Financial Group Inc. AFA: US ...
Stock name Symbol Country of origin The Taiwan Fund, Inc. TWN: Hong Kong: Taiwan Semiconductor Manufacturing Company Ltd. TSM: Taiwan: Takeda Pharmaceutical Company Limited
Cellectis has developed CAR T-cell treatments for blood cancer. [11] Most CAR-T therapies under development as of 2017 involved taking T-cells from the person with cancer and applying gene therapy to those cells to activate them to attack the person's cancer; an autologous cell therapy approach.
For example, $225K would be understood to mean $225,000, and $3.6K would be understood to mean $3,600. Multiple K's are not commonly used to represent larger numbers. In other words, it would look odd to use $1.2KK to represent $1,200,000. Ke – Is used as an abbreviation for Cost of Equity (COE).
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
The NASDAQ Biotechnology Index is a stock market index made up of securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either the Biotechnology or the Pharmaceutical industry. [1] A list of the 225 components of the index is published online.